Marinomed Granted European Patent for Antiviral Polymer

Posted On: May 12, 2009

Marinomed Biotechnologie GmbH, a German company focused on the development of innovative therapies in the indications of virology and immunology, announced today that it has been granted European Patent No. 0001842546, entitled ‘Antiviral polymer’ by the European Patent Office. The patent, which was granted in March, covers the use of a specific polymer for the prophylactic and therapeutic treatment of rhinovirus infections.

Dr Andreas Grassauer, CEO and co-founder of Marinomed, commented: “We are delighted that this first patent has been granted. This is the first of several patent applications that were filed in order to protect our intellectual property around products for the treatment of respiratory viruses.”

Marinomed has a pipeline of natural, mainly marine derived, compounds, for the treatment of respiratory illnesses and immunological disorders. The Company’s first product, the anti-viral nasal spray COLDAMARIS prophylactic which contains Carragelose®, was launched in 2008 for the prevention of and treatment of the common cold and viral-induced respiratory infections.

More Info